In response to characteristic hypoxic stress in the TME, tumor cells trigger a variety of signaling pathways in which oxygen-sensitive HIF-1, a crucial transcriptional activator, can upregulate the transcription of over 100 hypoxia-inducible genes. The gene discussed is HIF1A; the disease is neoplasm.